Product Information
TRI FEMYNOR 28 TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.1346 per EA under NDC 69238160706. Its NADAC has been published 371 times since Aug 30, 2017.
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238160706
Classification
Generic
Dosage Form
KIT
Last Updated
9/18/2024
Approval Type
Generic (ANDA)
FDA Application
ANDA203870On Market Since
10/28/2016
Price Statistics
The NADAC for TRI FEMYNOR 28 TABLET has been published 371 times since Aug 30, 2017, and over the history we have for it it has declined 48.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1346 per EA |
|---|---|
| All-time high | $0.2726 (Oct 11, 2017) |
| All-time low | $0.1072 (Jul 17, 2024) |
| Median price | $0.1832 |
| Average price | $0.1808 |
| Largest weekly change | -19.9% (Jul 17, 2024) |
| Weeks tracked | 371 |
| Tracking since | Aug 30, 2017 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TRI FEMYNOR 28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRI FEMYNOR 28 TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $0.1346 per EA (NDC 69238160706), effective Oct 2, 2024.
How has the price of TRI FEMYNOR 28 TABLET changed over time?
Over the history we have for it, the NADAC for TRI FEMYNOR 28 TABLET has declined 48.1%. It has been tracked across 371 weekly CMS publications since Aug 30, 2017.
What are the highest and lowest recorded NADAC prices for TRI FEMYNOR 28 TABLET?
Since Aug 30, 2017, the NADAC for TRI FEMYNOR 28 TABLET has ranged from a low of $0.1072 (Jul 17, 2024) to a high of $0.2726 (Oct 11, 2017), with a median of $0.1832 per EA.
Are there cheaper alternatives to TRI FEMYNOR 28 TABLET?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TRI-LO-ESTARYLLA TABLET, is $0.1049 per EA — about 22% below TRI FEMYNOR 28 TABLET.
Who manufactures TRI FEMYNOR 28 TABLET?
TRI FEMYNOR 28 TABLET (NDC 69238160706) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification